Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline

Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline

Aim: To establish a p53-negative osteosarcoma (OS) SaOS-2 cellular subline exhibiting resistance to specific chemotherapeutic agents, including topoisomerase II inhibitors, taxanes, and vinca alkaloids. Methods: The OS subline exhibiting resistance to the chemotherapeutic agents indicated above was...

Full description

Bibliographic Details
Main Authors:	Sergei Boichuk, Firyuza Bikinieva, Elena Valeeva, Pavel Dunaev, Maria Vasileva, Pavel Kopnin, Ekaterina Mikheeva, Tatyana Ivoilova, Ilshat Mustafin, Aigul Galembikova
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Diagnostics
Subjects:	Osteosarcoma (OS) ABC-transporters paclitaxel doxorubicin resistance apoptosis
Online Access:	https://www.mdpi.com/2075-4418/13/16/2646

Similar Items

Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells
by: Sergei Boichuk, et al.
Published: (2022-03-01)

Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma
by: Yanlong Xu, et al.
Published: (2023-07-01)

Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary <i>KIT</i> Mutations
by: Sergei Boichuk, et al.
Published: (2023-11-01)

Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
by: Hadeel Halalsheh, et al.
Published: (2023-07-01)

Chitosan-Boric Acid Scaffolds for Doxorubicin Delivery in the Osteosarcoma Treatment
by: Luka Dornjak, et al.
Published: (2022-11-01)

Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines
by: Ya-Ting Yang, et al.
Published: (2022-08-01)

Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
by: Martina Godel, et al.
Published: (2020-06-01)

Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil
by: Marilia Polo Minguete-e-Silva, et al.
Published: (2021-10-01)

Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma
by: Weihai Liu, et al.
Published: (2017-09-01)

Osteosarcoma cells can reproduce into tumorigenic cells by escaping chemotherapy-induced cell senescence
by: ZHANG Liang, LIU Ming-yong, LIU Peng, XUE Xin, ZHANG Liang-min, GUO Qiao-nan, ZHAO Jian-hua
Published: (2020-02-01)

Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells
by: Isabella Giacomini, et al.
Published: (2023-02-01)

Recent advances in hydrogels-based osteosarcoma therapy
by: Hao Tian, et al.
Published: (2022-10-01)

Doxorubicin-Loaded Lipid Nanoparticles Coated with Calcium Phosphate as a Potential Tool in Human and Canine Osteosarcoma Therapy
by: Daniela Chirio, et al.
Published: (2022-06-01)

Development, Characterization and Cell Viability Inhibition of PVA Spheres Loaded with Doxorubicin and 4′-Amino-1-Naphthyl-Chalcone (D14) for Osteosarcoma
by: Viviane Seba, et al.
Published: (2021-08-01)

Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis
by: Wei H, et al.
Published: (2022-08-01)

Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair
by: Sergei Boichuk, et al.
Published: (2020-11-01)

Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
by: Taurean Brown, et al.
Published: (2021-02-01)

Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study
by: Jiaqiang Wang, et al.
Published: (2023-11-01)

Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells
by: Xinru Wang, et al.
Published: (2024-02-01)

TIPE2 Mediates the Suppressive Effects of Shikonin on MMP13 in Osteosarcoma Cells
by: Biyong Deng, et al.
Published: (2015-12-01)

Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
by: Ingrid Lilienthal, et al.
Published: (2020-09-01)

Inhibition of FGF2-Mediated Signaling in GIST—Promising Approach for Overcoming Resistance to Imatinib
by: Sergei Boichuk, et al.
Published: (2020-06-01)

Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells
by: Alessia Salzillo, et al.
Published: (2021-08-01)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
by: Massimo Serra, et al.
Published: (2021-09-01)

The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site
by: Sergei Boichuk, et al.
Published: (2021-09-01)

Long intergenic non-coding RNA DIO3OS promotes osteosarcoma metastasis via activation of the TGF-β signaling pathway: a potential diagnostic and immunotherapeutic target for osteosarcoma
by: Jinghong Yuan, et al.
Published: (2023-09-01)

A new approach to the development and assessment of doxorubicin-loaded nanoliposomes for the treatment of osteosarcoma in 2D and 3D cell culture systems
by: Mastaneh Parchami, et al.
Published: (2023-05-01)

Intelligent structure prediction and visualization analysis of non-coding RNA in osteosarcoma research
by: Longhao Chen, et al.
Published: (2024-03-01)

BMI1 promotes osteosarcoma proliferation and metastasis by repressing the transcription of SIK1
by: Qiang Wang, et al.
Published: (2022-03-01)

A New Paclitaxel Formulation Based on Secretome Isolated from Mesenchymal Stem Cells Shows a Significant Cytotoxic Effect on Osteosarcoma Cell Lines
by: Alessia Giovanna Santa Banche Niclot, et al.
Published: (2023-09-01)

Primary osteosarcoma of the breast
by: Hung-An Huang, et al.
Published: (2021-01-01)

Synthesis, characterization, and evaluation of pH-sensitive doxorubicin-loaded functionalized graphene oxide in osteosarcoma cells
by: Forough Alemi, et al.
Published: (2023-05-01)

Deguelin Inhibits the Migration and Invasion of U-2 OS Human Osteosarcoma Cells via the Inhibition of Matrix Metalloproteinase-2/-9 in Vitro
by: Hung-Sheng Shang, et al.
Published: (2014-10-01)

m6A-modified circARHGAP12 promotes the aerobic glycolysis of doxorubicin-resistance osteosarcoma by targeting c-Myc
by: Dawei Zhang, et al.
Published: (2024-01-01)

DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination
by: Xin Wang, et al.
Published: (2023-05-01)

Different Subtypes of Osteosarcoma: Histopathological Patterns and Clinical Behaviour
by: Emel Rothzerg, et al.
Published: (2023-05-01)

Identification of a novel MYC target gene set signature for predicting the prognosis of osteosarcoma patients
by: Deliang Gong, et al.
Published: (2023-06-01)

Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma
by: Julius C. Heemelaar, et al.
Published: (2022-11-01)

A guise of osteosarcoma: Chondroblastoma-like
by: Aditi Amit Byatnal, et al.
Published: (2013-01-01)

Piperine improves the sensitivity of osteosarcoma cells to doxorubicin by inducing apoptosis and inhibiting the PI3K/AKT/GSK-3β pathway
by: Yubin Qi, et al.
Published: (2023-03-01)